The global influenza virus infection market is anticipated to grow at a significant CAGR of 5.2% during the forecast period. The increasing prevalence of influenza infection is acting as an important factor that is driving the growth of the market. Influenza is a virus that affects the respiratory system, which includes the nose, throat, and lungs. The influenza virus has been constantly spreading, and creating regional problems that have resulted in thousands of deaths. According to data from the Centres for Disease Control and Prevention (CDC), more than 13 million flu cases have been reported so far in 2019-20. So, during the forecasted period, the rising occurrence of influenza infection is expected to boost the demand for the product.
Get Free Sample link @ https://www.omrglobal.com/request-sample/influenza-virus-infection-market
The COVID-19 pandemic had an unavoidable impact on routine immunisation programs in both developing and developed countries around the globe. Flu vaccination rates, on the other hand, have increased significantly during the COVID-19 pandemic as a result of factors such as increased pressure from health experts & departments and the extension of various government programs that provide free flu immunisation. Furthermore, increasing public knowledge of the increased risk of contracting COVID-19 if the flu weakens the immune system is another factor contributing to flu vaccination adoption. Vvvv
A full report of Global Influenza Virus Infection Market available @ https://www.omrglobal.com/industry-reports/influenza-virus-infection-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Influenza Virus Infection Market by Treatment
- Baloxavir marboxil
- Oseltamivir phosphate
Global Influenza Virus Infection Market by Influenza Type
- Influenza A
- Influenza B
Global Influenza Virus Infection Market by Distribution channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Abbott
- Alvogen
- Amneal Pharmaceuticals LLC
- Autoimmune Technologies, LLC
- ContraFect Corp.
- Lupin Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vir Biotechnology, Inc.
- Zydus Pharmaceuticals, Inc.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global influenza virus infection market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/influenza-virus-infection-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
